SCHEMBL1483353

SCHEMBL1483353

CC(CCCCC(=O)O)CC(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.50
FFAR4 Q5NUL3 2/20 0.48
FFAR1 O14842 2/20 0.48
TSHR P16473 4/20 0.48
NFKB1 P19838 1/20 0.48
PMP22 Q01453 1/20 0.48
ALDH1A1 P00352 3/20 0.47
GSTK1 Q9Y2Q3 2/20 0.47
AKR1B1 P15121 1/20 0.46
ENPEP Q07075 1/20 0.45
PPARG P37231 5/20 0.44
PPARD Q03181 5/20 0.44
PPARA Q07869 5/20 0.44
HDAC11 Q96DB2 4/20 0.44
GPR84 Q9NQS5 3/20 0.44
TLR2 O60603 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
FABP4 P15090 2/20 0.44
PTPN1 P18031 2/20 0.44
SLC22A6 Q4U2R8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL494465 0.98 TSHR (0.52) LMNAFFAR4FFAR1TSHRNFKB1
SCHEMBL2928747 0.98 TSHR (0.52) LMNAFFAR4FFAR1TSHRNFKB1
SCHEMBL494914 0.98 TSHR (0.52) LMNAFFAR4FFAR1TSHRNFKB1
SCHEMBL495661 0.98 TSHR (0.52) LMNAFFAR4FFAR1TSHRNFKB1
SCHEMBL7102763 0.98 TSHR (0.52) LMNAFFAR4FFAR1TSHRNFKB1
SCHEMBL494627 0.98 TSHR (0.52) LMNAFFAR4FFAR1TSHRNFKB1
SCHEMBL22612512 0.98 TSHR (0.52) LMNAFFAR4FFAR1TSHRNFKB1
SCHEMBL22612532 0.98 TSHR (0.52) LMNAFFAR4FFAR1TSHRNFKB1
SCHEMBL22612520 0.98 TSHR (0.52) LMNAFFAR4FFAR1TSHRNFKB1
SCHEMBL493872 0.98 TSHR (0.52) LMNAFFAR4FFAR1TSHRNFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120005152-A Method for synthesizing glycol-based polyester without catalyst and product thereof 浙江大学 2025-05-16 CN claimed
CN-113490721-B Modified copolyester resin and aqueous dispersion thereof 东洋纺MC株式会社 2024-01-16 CN claimed
CN-101463244-B Modified polyamide thermosol based on polyester and preparation thereof SHANGHAI TIANYANG HOTMELT ADHESIVES Co.,Ltd. (CN) 2012-02-01 CN claimed
US-20110076278-A1 Modulators of Hypoxia Inducible Factor-1 and Related Uses for the Treatment of Ocular Disorders BIONAUT PHARMACEUTICALS INC 2011-03-31 US claimed
CN-101463244-A Modified polyamide thermosol based on polyester and preparation thereof SHANGHAI TIANYANG HOT MELT ADH (CN) 2009-06-24 CN claimed
EP-1928470-A2 MODULATORS OF HYPOXIA INDUCIBLE FACTOR-1 AND RELATED USES FOR THE TREATMENT OF OCULAR DISORDERS Bionaut Pharmaceuticals (US) 2008-06-11 EP claimed
WO-2007016656-A2 MODULATORS OF HYPOXIA INDUCIBLE FACTOR-1 AND RELATED USES FOR THE TREATMENT OF OCULAR DISORDERS BTG INTERNATIONAL LIMITED (GB) 2007-02-08 WO claimed
US-12378404-B2 Modified copolymerized polyester resin and water dispersion thereof TOYOBO MC CORPORATION (JP) 2025-08-05 US disclosed
EP-3875539-B1 MODIFIED COPOLYMERIZED POLYESTER RESIN AND WATER DISPERSION THEREOF TOYOBO MC CORP (JP) 2025-07-16 EP disclosed
CN-120005152-A Method for synthesizing glycol-based polyester without catalyst and product thereof 浙江大学 2025-05-16 CN disclosed
CN-113490721-B Modified copolyester resin and aqueous dispersion thereof 东洋纺MC株式会社 2024-01-16 CN disclosed
US-20230000123-A1 SWEETENER AND FLAVOR COMPOSITIONS CONTAINING TERPENE GLYCOSIDES EPC Natural Products Co., Ltd (CN) 2023-01-05 US disclosed
US-20220339259-A1 ORALLY DELIVERED THERAPEUTICAL COMPOSITION AND USE THEREOF SHEN HAIFA (US) 2022-10-27 US disclosed
US-20110076278-A1 Modulators of Hypoxia Inducible Factor-1 and Related Uses for the Treatment of Ocular Disorders BIONAUT PHARMACEUTICALS INC 2011-03-31 US disclosed
CN-101463244-A Modified polyamide thermosol based on polyester and preparation thereof SHANGHAI TIANYANG HOT MELT ADH (CN) 2009-06-24 CN disclosed
EP-1928470-A2 MODULATORS OF HYPOXIA INDUCIBLE FACTOR-1 AND RELATED USES FOR THE TREATMENT OF OCULAR DISORDERS Bionaut Pharmaceuticals (US) 2008-06-11 EP disclosed
WO-2007016656-A2 MODULATORS OF HYPOXIA INDUCIBLE FACTOR-1 AND RELATED USES FOR THE TREATMENT OF OCULAR DISORDERS BTG INTERNATIONAL LIMITED (GB) 2007-02-08 WO disclosed
CN-1326920-A Dimethyl-decadial, its preparing method and its use KURARAY CO (JP) 2001-12-19 CN disclosed
US-4985508-A Process for the production of polyester-polyamide block polymers BAYER AKTIENGESELLSCHAFT (DE) 1991-01-15 US disclosed
US-3931058-A POLYGLYCIDYL COMPOUNDS, PROCESSES FOR THEIR MANUFACTURE AND USE CIBA-GEIGY AG (CH) 1976-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110076278-A1 Modulators of Hypoxia Inducible Factor-1 and Related Uses for the Treatment of Ocular Disorders HIF1A, HIF1AN, HYOU1 LMNA 1477/4885FFAR4 1944/4885FFAR1 1079/4885
US-20220339259-A1 ORALLY DELIVERED THERAPEUTICAL COMPOSITION AND USE THEREOF FABP2, SLC27A1, SLC27A2 LMNA 2441/4885FFAR4 26/4885FFAR1 154/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.